Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy
Liver fibrosis is an excess production of extracellular matrix proteins as a result of chronic liver disease which leads to cell death and organ dysfunction. The key cells involved in fibrogenesis are resident hepatic stellate cells (HSCs) which are termed myofibroblasts after activation, acquiring...
Main Authors: | Bárbara González-Fernández, Diana I. Sánchez, Javier González-Gallego, María J. Tuñón |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00579/full |
Similar Items
-
Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
by: Yonghua Bao, et al.
Published: (2017-10-01) -
Leucine-rich Repeats and Immunoglobulin 1 (LRIG1) Ameliorates Liver Fibrosis and Hepatic Stellate Cell Activation via Inhibiting Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P) Pathway
by: Wei Zhan, et al.
Published: (2020-08-01) -
Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
by: Sara Grassi, et al.
Published: (2019-07-01) -
Sphingosine 1-Phosphate Receptor 4 Expression in Colorectal Cancer Patients
by: Suchittra SAMUHASANEETO, et al.
Published: (2016-06-01) -
Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling
by: Michael Maceyka, et al.
Published: (2009-01-01)